Zobrazeno 1 - 10
of 734
pro vyhledávání: '"Jian-Hua Liu"'
Publikováno v:
ACS Omega, Vol 9, Iss 42, Pp 43106-43114 (2024)
Externí odkaz:
https://doaj.org/article/b0a6274c6c294056a90abb485874792b
Autor:
Shuai-Hua Li, Rui-Yun Wang, Jun-Kai Zhang, Kai-Fang Yi, Jian-Hua Liu, Hua Wu, Li Yuan, Ya-Jun Zhai, Gong-Zheng Hu
Publikováno v:
BMC Microbiology, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Bacteriophage has been renewed attention as a new antibacterial agent due to the limitations of antibiotic treatment. Bacteriophages are generally thought to be highly host specific and even strain specific, but a small number of
Externí odkaz:
https://doaj.org/article/8c5ea966965048efb8e29e834d84b64a
Autor:
Jiangdian Song, Jie Zhang, Guichao Liu, Zhexu Guo, Hongxian Liao, Wenhui Feng, Wenxiang Lin, Lei Li, Yi Zhang, Yuxiang Yang, Bin Liu, Ruibang Luo, Hao Chen, Siyun Wang, Jian-Hua Liu
Publikováno v:
Insights into Imaging, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Objectives The clinical decision-making regarding choosing surgery alone (SA) or surgery followed by postoperative adjuvant chemotherapy (SPOCT) in esophageal squamous cell carcinoma (ESCC) remains controversial. We aim to propose a pre-ther
Externí odkaz:
https://doaj.org/article/69db9cc9b0344206b3fb4f80947ed568
Autor:
Lingxian Yi, Kaiyang Yu, Guolong Gao, Rongmin Zhang, Luchao Lv, Daojin Yu, Jun Yang, Jian-Hua Liu
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 36, Iss , Pp 365-370 (2024)
ABSTRACT: IncX4 plasmids are one of the most epidemiologically successful vehicles for mcr-1 spread. Here we found that the IncX4 plasmids carried two different replication proteins encoded by genes pir-1 and pir-2, respectively, but mcr-1 was only c
Externí odkaz:
https://doaj.org/article/cfc42d16ec3a4bcca402ca27991f766e
Autor:
Xiao-die Cui, Xiao-kang Liu, Xiao-yuan Ma, Shuai-hua Li, Jun-kai Zhang, Rong-jia Han, Kai-fang Yi, Jian-hua Liu, Yu-shan Pan, Dan-dan He, Gong-zheng Hu, Ya-jun Zhai
Publikováno v:
mSphere, Vol 9, Iss 6 (2024)
ABSTRACT The appearance and prevalence of multidrug-resistance (MDR) Gram-negative bacteria (GNB) have limited our antibiotic capacity to control bacterial infections. The clinical efficacy of colistin (COL), considered as the “last resort” for t
Externí odkaz:
https://doaj.org/article/43da189e70484bb999b696a22c6ad01f
Autor:
Ying Huang, Yan Zhu, Hui-Ying Yue, Yi-Yun Liu, Li-Min Deng, Luchao Lv, Chengzhen Wang, Jun Yang, Jian-Hua Liu
Publikováno v:
mSystems, Vol 9, Iss 6 (2024)
ABSTRACT Polymyxin is used as a last resort antibiotics for infections caused by multi-drug resistant (MDR) Gram-negative bacteria and is often combined with other antibiotics to improve clinical effectiveness. However, the synergism of colistin and
Externí odkaz:
https://doaj.org/article/e666bc5f0f55482882372637f8b54034
Autor:
Yue Hu, Si-Yu Zhang, Wen-Cheng Sun, Ya-Ru Feng, Hua-Rui Gong, Duo-Liang Ran, Bao-Zhong Zhang, Jian-Hua Liu
Publikováno v:
Viruses, Vol 16, Iss 9, p 1472 (2024)
Equid alphaherpesvirus 1 (EHV-1) has been linked to the emergence of neurological disorders, with the horse racing industry experiencing significant impacts from outbreaks of equine herpesvirus myeloencephalopathy (EHM). Building robust immune memory
Externí odkaz:
https://doaj.org/article/3e2472ca69874fd78cdd47affdb5353e
Publikováno v:
mBio, Vol 15, Iss 5 (2024)
ABSTRACTAntibiotic resistance could rapidly emerge from acquiring the mobile antibiotic resistance genes, which are commonly evolved from an intrinsic gene. The emergence of the plasmid-borne mobilized efflux pump gene cluster tmexCD1-toprJ1 renders
Externí odkaz:
https://doaj.org/article/3f366eaeaf43475db6cab0bac06191fd
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 35, Iss , Pp 190-192 (2023)
Externí odkaz:
https://doaj.org/article/4978c9ba49ce443698421410a5b57ae0
Autor:
Jian‐Hua Liu, Ju‐Ze Lin, Qianhui Qiu, Changbin Zhu, Weiwei Li, Qian Li, Zhan Huang, Xueer Xia, Guibin Qiao, Jiming Tang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 14, Pp 1294-1305 (2023)
Abstract Background The use of neoadjuvant immunotherapy plus chemotherapy has revolutionized the management of esophageal squamous cell carcinoma (ESCC) patients. Nevertheless, patients who would maximally benefit from these therapies have not been
Externí odkaz:
https://doaj.org/article/c681290086f2477bae9ae8012a8b3e09